Startups

Desentum is a biotechnology company in Finland developing an allergy vaccine that harnesses the immune system.

Summary

Seedtable Score
  • 14
Locations
Company Size
  • 1 to 10 employees
Last Stage Round
  • Unknown

Total funding Amount

$8.6M

Fundraising History

  • Jan 01 '22 Unknown
    $9.1M
  • Nov 01 '19 Unknown
    $4.4M

Investors